Insider Trading activities of Zonagen Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Zonagen Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Zonagen Inc since year 2005. Table 2 shows the detailed insider transactions of Zonagen Inc since 2005. The reporting company's ticker symbol is RPRX. The reporting company's CIK number is 897075.
The total value of stock buying since 2005 is $48,514,601.
The total value of stock sales since 2005 is $4,011,739.
The total value of stock option exercises since 2005 is $319,535.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Zonagen Inc (RPRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2016-12 20,000 $32,000 0 $0 0 $0
2016-11 0 $0 3,305 $6,444 0 $0
2016-02 10,000 $9,300 0 $0 0 $0
2016-01 33,677 $37,953 0 $0 0 $0
2014-11 8,200 $77,226 0 $0 0 $0
2014-09 200 $2,868 0 $0 0 $0
2014-08 4,100 $56,911 0 $0 0 $0
2014-01 0 $0 0 $0 10,000 $96,000
2013-11 500 $7,485 0 $0 0 $0
2013-10 5,000 $95,772 0 $0 0 $0
2013-02 1,000 $11,890 0 $0 0 $0
2012-10 0 $0 0 $0 3,333 $14,765
2012-09 0 $0 0 $0 21,249 $208,770
2012-05 554,500 $3,085,303 0 $0 0 $0
2012-04 3,000 $11,565 0 $0 0 $0
2012-03 5,000 $19,965 0 $0 0 $0
2011-08 750,000 $4,718,000 0 $0 0 $0
2011-03 166,500 $875,332 0 $0 0 $0
2011-02 247,195 $1,092,956 0 $0 0 $0
2010-10 13,000 $17,810 0 $0 0 $0
2010-07 5,000 $1,500 0 $0 0 $0
2010-06 37,500 $16,350 0 $0 0 $0
2009-12 0 $0 935,903 $644,998 0 $0
2009-11 0 $0 804,000 $576,942 0 $0
2009-03 4,000 $25,640 0 $0 0 $0
2008-11 400 $3,920 0 $0 0 $0
2008-10 4,186,960 $27,293,030 0 $0 0 $0
2008-05 1,600 $14,742 0 $0 0 $0
2008-04 6,000 $52,675 0 $0 0 $0
2008-03 125,000 $1,065,406 302,057 $2,783,355 0 $0
2008-02 51,000 $423,797 0 $0 0 $0
2008-01 35,500 $320,365 0 $0 0 $0
2007-12 691,600 $6,257,755 0 $0 0 $0
2007-10 218,000 $2,711,683 0 $0 0 $0
2007-01 2,000 $24,400 0 $0 0 $0
2006-12 6,980 $45,951 0 $0 0 $0
2006-11 4,025 $25,044 0 $0 0 $0
2006-10 2,000 $16,356 0 $0 0 $0
2006-07 3,000 $24,629 0 $0 0 $0
2006-05 1,000 $10,990 0 $0 0 $0
2006-01 700 $3,486 0 $0 0 $0
2005-04 2,425 $7,067 0 $0 0 $0
2005-03 5,500 $17,479 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Zonagen Inc insiders (RPRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-12-09 Podolski Joseph (President and CEO) Buy 20,000 1.60 32,000
2016-11-21 Masterson Nola E Sale 3,305 1.95 6,444
2016-02-18 Podolski Joseph (President and CEO) Buy 10,000 .93 9,300
2016-01-27 Anderson Katherine (Chief Financial Officer) Buy 12,000 1.08 12,960
2016-01-25 Wernicke J. F. (Chief Medical Officer) Buy 10,000 1.12 11,200
2016-01-07 Podolski Joseph (President and CEO) Buy 3,500 1.14 3,989
2016-01-06 Podolski Joseph (President and CEO) Buy 8,177 1.20 9,804
2014-11-12 Anderson Katherine (Chief Financial Officer) Buy 3,500 9.41 32,952
2014-11-12 Podolski Joseph (President and CEO) Buy 4,700 9.42 44,274
2014-09-15 Masterson Nola E Buy 200 14.34 2,868
2014-08-14 Anderson Katherine (Chief Financial Officer) Buy 2,000 13.85 27,700
2014-08-14 Podolski Joseph (President and CEO) Buy 2,100 13.91 29,211
2014-01-10 Cain Daniel F Option Ex 10,000 9.60 96,000
2013-11-12 Cain Daniel F (Director) Buy 500 14.97 7,485
2013-10-25 Anderson Katherine (Chief Financial Officer) Buy 1,000 17.90 17,900
2013-10-25 Podolski Joseph (President and CEO) Buy 3,000 18.03 54,102
2013-10-10 Anderson Katherine (Chief Financial Officer) Buy 1,000 23.77 23,770
2013-02-01 Anderson Katherine (Chief Financial Officer) Buy 1,000 11.89 11,890
2012-10-29 Wyllie Michael (Director) Option Ex 3,333 4.43 14,765
2012-09-12 Wyllie Michael (Director) Option Ex 9,999 4.43 44,295
2012-09-12 Masterson Nola E (Director) Option Ex 11,250 14.62 164,475
2012-05-14 Edelman Joseph Buy 59,500 7.38 439,288
2012-05-11 Edelman Joseph Buy 170,000 6.35 1,079,840
2012-05-10 Edelman Joseph Buy 325,000 4.82 1,566,175
2012-04-13 Anderson Katherine (Chief Financial Officer) Buy 3,000 3.85 11,565
2012-03-05 Podolski Joseph (President and CEO) Buy 5,000 3.99 19,965
2011-08-19 Edelman Joseph Buy 725,600 6.25 4,535,000
2011-08-12 Edelman Joseph Buy 800 7.50 6,000
2011-08-09 Edelman Joseph Buy 3,800 7.50 28,500
2011-08-08 Edelman Joseph Buy 4,700 7.50 35,250
2011-08-05 Edelman Joseph Buy 15,100 7.50 113,250
2011-03-16 Perceptive Life Sciences Master Fund Ltd Buy 86,500 5.21 450,232
2011-03-07 Perceptive Life Sciences Master Fund Ltd Buy 30,000 6.47 194,100
2011-03-01 Perceptive Life Sciences Master Fund Ltd Buy 50,000 4.62 231,000
2011-02-28 Perceptive Life Sciences Master Fund Ltd Buy 88,273 4.46 393,697
2011-02-25 Perceptive Life Sciences Master Fund Ltd Buy 48,922 4.49 219,659
2011-02-24 Perceptive Life Sciences Master Fund Ltd Buy 110,000 4.36 479,600
2010-10-15 Podolski Joseph (President and CEO) Buy 13,000 1.37 17,810
2010-07-07 Masterson Nola E (Director) Buy 5,000 .30 1,500
2010-06-24 Masterson Nola E (Director) Buy 5,000 .41 2,050
2010-06-22 Podolski Joseph (President and CEO) Buy 32,500 .44 14,300
2009-12-21 Efficacy Biotech Master Fund Ltd. Sale 76,703 .65 50,163
2009-12-18 Efficacy Biotech Master Fund Ltd. Sale 30,000 .68 20,280
2009-12-17 Efficacy Biotech Master Fund Ltd. Sale 50,100 .70 35,220
2009-12-15 Efficacy Biotech Master Fund Ltd. Sale 181,700 .67 121,739
2009-12-14 Efficacy Biotech Master Fund Ltd. Sale 77,900 .70 54,452
2009-12-11 Efficacy Biotech Master Fund Ltd. Sale 126,500 .70 88,044
2009-12-02 Lappe Mark Sale 262,000 .70 182,352
2009-12-01 Lappe Mark Sale 131,000 .71 92,748
2009-11-30 Lappe Mark Sale 148,000 .71 105,524
2009-11-23 Lappe Mark Sale 227,000 .70 159,127
2009-11-20 Lappe Mark Sale 215,000 .71 152,005
2009-11-19 Lappe Mark Sale 214,000 .75 160,286
2009-03-05 Podolski Joseph (Chief Executive Officer) Buy 4,000 6.41 25,640
2008-11-18 Harder Jeffrey R (Director) Buy 400 9.80 3,920
2008-10-31 Kayyem Jon Faiz (10% Owner) Buy 11,300 7.76 87,688
2008-10-31 Lappe Mark (Director) Buy 11,300 7.76 87,688
2008-10-29 Kayyem Jon Faiz (10% Owner) Buy 24,400 6.97 170,068
2008-10-29 Lappe Mark (Director) Buy 24,400 6.97 170,068
2008-10-28 Kayyem Jon Faiz (10% Owner) Buy 9,892 6.87 67,958
2008-10-28 Lappe Mark (Director) Buy 9,892 6.87 67,958
2008-10-27 Lappe Mark (Director) Buy 14,825 6.85 101,551
2008-10-27 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 14,825 6.85 101,551
2008-10-24 Lappe Mark (Director) Buy 30,000 6.89 206,700
2008-10-24 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 30,000 6.89 206,700
2008-10-23 Lappe Mark (Director) Buy 17,309 6.32 109,392
2008-10-23 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 17,309 6.32 109,392
2008-10-22 Harder Jeffrey R (Director) Buy 4,000 6.47 25,880
2008-10-17 Lappe Mark (Director) Buy 60,000 6.42 385,200
2008-10-17 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 60,000 6.42 385,200
2008-10-14 Masterson Nola E (Director) Buy 400 7.00 2,800
2008-10-13 Lappe Mark (Director) Buy 15,000 6.82 102,300
2008-10-13 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 15,000 6.82 102,300
2008-10-10 Lappe Mark (Director) Buy 15,300 6.23 95,319
2008-10-10 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 15,300 6.23 95,319
2008-10-07 Podolski Joseph (President and CEO) Buy 4,400 7.16 31,504
2008-10-07 Ploth Louis Jr (VP & Chief Financial Officer) Buy 2,800 7.09 19,852
2008-10-02 Lappe Mark (Director) Buy 1,846,154 6.50 12,000,001
2008-10-02 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 1,846,154 6.50 12,000,001
2008-10-02 Reed John C (Director) Buy 25,000 6.50 162,500
2008-05-23 Harder Jeffrey R (Director) Buy 1,000 9.14 9,140
2008-05-20 Fourcroy Jean L Md Phd Mph (Director) Buy 600 9.34 5,602
2008-04-22 Ploth Louis Jr (VP & Chief Financial Officer) Buy 500 8.77 4,385
2008-04-16 Podolski Joseph (President and CEO) Buy 1,500 8.86 13,290
2008-04-16 Ploth Louis Jr (VP & Chief Financial Officer) Buy 2,000 8.75 17,504
2008-04-15 Harder Jeffrey R (Director) Buy 1,000 8.50 8,500
2008-04-09 Podolski Joseph (President and CEO) Buy 1,000 9.00 8,996
2008-03-27 Efficacy Biotech Master Fund Ltd. (10% Owner) Sale 55,800 9.55 532,890
2008-03-26 Efficacy Biotech Master Fund Ltd. (10% Owner) Sale 10,000 9.82 98,200
2008-03-25 Efficacy Biotech Master Fund Ltd. (10% Owner) Sale 60,000 9.58 574,800
2008-03-24 Efficacy Biotech Master Fund Ltd. (10% Owner) Sale 50,000 9.61 480,500
2008-03-20 Efficacy Biotech Master Fund Ltd. (10% Owner) Sale 34,000 8.94 303,960
2008-03-18 Efficacy Biotech Master Fund Ltd. (10% Owner) Sale 10,600 8.90 94,340
2008-03-17 Efficacy Biotech Master Fund Ltd. (10% Owner) Sale 55,357 8.54 472,748
2008-03-14 Efficacy Biotech Master Fund Ltd. (10% Owner) Sale 26,300 8.59 225,917
2008-03-12 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 50,000 8.50 425,000
2008-03-10 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 40,000 8.46 338,400
2008-03-07 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 34,500 8.63 297,735
2008-03-03 Harder Jeffrey R (Director) Buy 500 8.54 4,271
2008-02-29 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 30,000 8.27 248,100
2008-02-28 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 20,000 8.35 167,000
2008-02-26 Harder Jeffrey R (Director) Buy 500 8.79 4,397
2008-02-04 Masterson Nola E (Director) Buy 500 8.60 4,300
2008-01-24 Harder Jeffrey R (Director) Buy 1,000 8.90 8,905
2008-01-07 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 19,500 9.08 177,060
2008-01-04 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 15,000 8.96 134,400
2007-12-31 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 54,100 9.43 510,163
2007-12-31 Podolski Joseph (President and CEO) Buy 1,000 9.36 9,360
2007-12-28 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 70,000 9.32 652,400
2007-12-21 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 40,000 9.38 375,200
2007-12-20 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 60,000 9.49 569,400
2007-12-19 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 43,500 9.84 428,040
2007-12-18 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 42,100 9.79 412,158
2007-12-14 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 120,000 9.78 1,173,600
2007-12-13 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 40,100 8.70 348,870
2007-12-06 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 60,000 7.96 477,600
2007-12-05 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 39,300 8.18 321,474
2007-12-04 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 50,000 8.35 417,500
2007-12-03 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 71,500 7.86 561,990
2007-10-25 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 17,000 12.69 215,713
2007-10-25 Podolski Joseph (President and CEO) Buy 1,000 12.66 12,660
2007-10-24 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 25,000 12.55 313,725
2007-10-23 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 25,000 12.53 313,350
2007-10-22 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 25,000 12.18 304,550
2007-10-19 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 40,500 12.34 499,608
2007-10-18 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 21,900 12.48 273,333
2007-10-17 Efficacy Biotech Master Fund Ltd. (10% Owner) Buy 62,600 12.44 778,744
2007-01-11 Van As Andre Md, Phd (Chief Medical Officer) Buy 2,000 12.20 24,400
2006-12-26 Van As Andre Md, Phd (Chief Medical Officer) Buy 410 11.85 4,858
2006-12-19 Van As Andre Md, Phd (Chief Medical Officer) Buy 2,000 7.08 14,160
2006-12-01 Harder Jeffrey R (Director) Buy 2,000 5.88 11,770
2006-12-01 Podolski Joseph (President and CEO) Buy 1,500 5.90 8,850
2006-12-01 Ploth Louis Jr (VP & Chief Financial Officer) Buy 1,070 5.90 6,313
2006-11-28 Ploth Louis Jr (VP & Chief Financial Officer) Buy 1,000 5.72 5,720
2006-11-27 Masterson Nola E (Director) Buy 100 5.59 559
2006-11-14 Podolski Joseph (President and CEO) Buy 2,000 5.71 11,416
2006-11-01 Ploth Louis Jr (VP & Chief Financial Officer) Buy 925 7.95 7,349
2006-10-27 Podolski Joseph (President and CEO) Buy 2,000 8.18 16,356
2006-07-27 Cain Daniel F (Director) Buy 2,000 8.34 16,680
2006-07-06 Harder Jeffrey R (Director) Buy 1,000 7.95 7,949
2006-05-05 Podolski Joseph (President and CEO) Buy 1,000 10.99 10,990
2006-01-03 Podolski Joseph (President and CEO) Buy 700 4.98 3,486
2005-04-05 Podolski Joseph (President and CEO) Buy 2,000 2.90 5,800
2005-04-05 Ploth Louis Jr (Chief Financial Officer) Buy 425 2.98 1,267
2005-03-21 Ploth Louis Jr (Chief Financial Officer) Buy 2,500 3.10 7,750
2005-03-09 Podolski Joseph (President and CEO) Buy 3,000 3.24 9,729

Insider trading activities including stock purchases, stock sales, and option exercises of RPRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Zonagen Inc (symbol RPRX, CIK number 897075) see the Securities and Exchange Commission (SEC) website.